The Journal of Organic Chemistry
Article
(petroleum ether); IR (film) νmax = 2952, 2921, 1636, 1248, 1168, 844
for 30 min at 0 °C, the reaction mixture was quenched with 1 mL of
water and extracted with ether. The organic layer was washed
successively with water and brine, dried over Na2SO4, and
concentrated in vacuo. The residue was purified by flash silica gel
column chromatography (petroleum ether/EtOAc = 5:1) to give
hydroxyl olefin 9b (18 mg, 83%) as a colorless oil: Rf = 0.31
(petroleum ether/EtOAc = 3:1); IR (film) νmax = 3360, 2944, 2856,
1650, 1457, 1671, 1072, 1028, 876 cm−1; 1H NMR (400 MHz,
CDCl3) δ 4.95 (s, 1H), 4.64 (s, 1H), 3.59 (d, 1H, J = 6.4 Hz), 2.93−
2.84 (m, 1H), 2.58−2.49 (m, 1H), 2.37 (t, 2H, J = 8.8 Hz), 2.25−2.18
(m, 1H), 1.78−1.70 (m, 1H), 1.69−1.57 (m, 3H), 1.33−1.22 (m, 2H),
1.15 (s, 3H), 0.98 (s, 3H), 0.92 (s, 3H); 13C NMR (100 MHz, CDCl3)
δ 159.7, 105.7, 80.7, 56.0, 55.0, 54.4, 49.9, 44.7, 42.0, 34.6, 30.7, 30.0,
28.2, 27.6, 24.2; HRMS (ESI) m/z [M + H]+ calcd for C15H25O,
221.1900; found, 221.1903.
(1R,3aS,3bR,6aR,7aS)-2,2,3b-Trimethyl-4-methylenedecahydro-
1H-cyclopenta[a]pentalen-1-ol (9c). To a mixture of compound 9b
(20 mg, 0.09 mmol) in dry benzene (1 mL) were added 4-
bromophenylisocyanate (22 mg, 0.11 mmol) and Et3N (0.10 mL, 0.70
mmol) at 0 °C. The resulting mixture was stirred at room temperature
overnight and quenched with 1 mL of water. The reaction mixture was
extracted with ether, and the organic layer was washed successively
with water and brine, dried over Na2SO4, and concentrated in vacuo.
The residue was purified by flash silica gel column chromatography
(petroleum ether/EtOAc = 10:1) to give 9c (38 mg, 78%) as a
colorless solid: Rf = 0.58 (petroleum ether/EtOAc = 10:1); mp 123−
125 °C; IR (film) νmax = 3320, 2957, 2867, 1735, 1459, 1379, 1129,
1094, 912, 743 cm−1; 1H NMR (400 MHz, CDCl3) δ 7.40 (d, 2H, J =
8.8 Hz), 7.29 (d, 2H, J = 8.8 Hz), 6.56 (br s, 1H), 4.96 (s, 1H), 4.65 (s,
1H), 4.62 (d, 1H, J = 6.0 Hz), 2.59−2.52 (m, 1H), 2.50−2.36 (m,
3H), 2.22−2.12 (m, 2H), 1.75−1.70 (m, 1H), 1.64−1.60 (m, 1H),
1.55−1.47 (m, 2H), 1.13 (s, 3H), 1.04 (s, 3H), 0.95 (s, 3H); 13C NMR
(100 MHz, CDCl3) δ 159.4, 153.3, 137.2, 131.9 (2C), 127.6, 120.1,
115.7, 105.6, 83.7, 55.6, 54.8, 54.3, 49.0, 43.9, 43.1, 34.7, 31.3, 30.6,
28.1, 27.6, 24.4; HRMS (ESI) m/z [M + H]+ calcd for C22H29BrNO2,
418.1376; found, 418.1380. X-ray crystallographic data of 9c:
C22H28BrNO2, monoclinic, space group: Cc, a = 11.002 (4) Å, b =
24.264 (8) Å, c = 9.485 (3) Å, β = 123.324 (14) °, Z = 4, dcalcd = 1.313
g/cm3, R1(I > 2σ(I)) = 0.0633, wR2 = 0.0766.
1
cm−1; H NMR (300 MHz, CDCl3) δ 5.05 (s, compound 5b, 1H),
5.02 (s, compound 7b, 0.3H), 4.52−4.45 (m, compound 7b, 0.4H),
3.19 (dd, compound 5b, 1H, J = 6.8, 12.0 Hz), 3.10 (dd, compound
5b, 1H, J = 9.6, 12.0 Hz), 3.00−2.98 (m, 1H), 2.80−2.61 (m, 1H),
2.31−2.17 (m, 2H), 2.13−1.98 (m, 3H), 1.57−1.49 (m, 3H), 0.03 (s,
13H); 13C NMR (75 MHz, CDCl3) δ 144.7, 134.9, 124.5, 116.7, 48.3,
38.2, 36.9, 35.0, 31.5, 31.2, 29.7, 28.1, 27.9, 21.7, 15.6, −1.1, −1.3; EI−
MS (m/z) M+ 294 (1.9%), 167 (39%), 79 (35%), 73 (100%).
5,5-Dimethyl-2-((2-methyl-3-((trimethylsilyl)methyl)cyclopent-2-
en-1-yl)methyl)cyclopent-2-enone (3). To a stirred mixture of
diisopropylamine (0.34 mL, 2.40 mmol) in dry THF (4 mL) was
added n-BuLi (1.6 M in hexane, 1.38 mL, 2.20 mmol) dropwise at 0
°C under N2, and the mixture was stirred for 30 min. The resulting
LDA solution was cooled to −78 °C, and a mixture of 8 (220 mg, 2.00
mmol) and HMPA (1.0 mL, 5.40 mmol) in dry THF (3 mL) was
added dropwise, and the solution was stirred for 30 min. A mixture of
5a and 7a (2:1 (GC), 940 mg, 3.00 mmol) in 5 mL of THF was added
dropwise over 10 min via syringe at −78 °C. The reaction mixture was
warmed gradually to room temperature over 1 h, quenched with 1 mL
of saturated aqueous NH4Cl, and extracted with diethyl ether. The
ethereal layer was washed successively with water and brine, dried over
Na2SO4, and concentrated in vacuo. The residue was purified by flash
silica gel column chromatography (petroleum ether/EtOAc = 10:1) to
give compound 3 (104 mg, 30%) as a colorless oil: Rf = 0.65
(petroleum ether/EtOAc = 8:1); IR (film) νmax = 2956, 2867, 1704,
1440, 1247, 1146, 1022, 841, 692 cm−1; 1H NMR (400 MHz, CDCl3)
δ 7.19 (s, 1H), 2.72 (br s, 1H), 2.49−2.42 (m, 2H), 2.21−2.11 (m,
2H), 1.96−1.85 (m, 2H), 1.55 (s, 3H), 1.49−1.47 (m, 2H), 1.34−1.26
(m, 2H), 1.12 (s, 6H), −0.00 (s, 9H); 13C NMR (100 MHz, CDCl3) δ
214.3, 154.7, 142.7, 133.6, 130.5, 47.9, 43.7, 43.0, 36.9, 29.3, 28.4, 25.2,
25.1, 19.4, 12.6, −0.8 (3C, −Si(CH3)3); HRMS (ESI) m/z [M + H]+
calcd for C18H31OSi, 291.2139; found, 291.2135.
(3aR,3bR,6aR,7aR)-2,2,3b-Trimethyl-4-methylenedecahydro-1H-
cyclopenta[a]pentalen-1-one (9) and (3aS,3bR,6aR,7aS)-2,2,3b-
Trimethyl-4-methylenedecahydro-1H-cyclopenta[a]pentalen-1-one
(9a). To a mixture of TBAF trihydrate (62 mg, 0.24 mmol) in dry
DMF (3 mL) was added powdered 4 Å molecular sieves (50 mg).
After stirring for 15 min, the mixture was filtered, and the resulting
filtrate was transferred to a reaction vessel containing 100 mg of 4 Å
molecular sieves and HMPA (0.40 mL, 2.16 mmol). After stirring for
15 min at room temperature, a solution of allylsilane 3 (63 mg, 0.22
mmol) in 1 mL of dry DMF was added to the above slurry over 30
min via a syringe pump. The reaction mixture was stirred at room
temperature for 12 h, quenched with 1 mL of water, and extracted with
ether. The organic layer was washed successively with water and brine,
dried over Na2SO4, and concentrated in vacuo. The residue was
purified by flash silica gel column chromatography (petroleum ether/
EtOAc = 10:1) to give compounds 9 (15 mg, 30%) and 9a (15 mg,
30%) as colorless oils, respectively. Compound 9: Rf = 0.55
(petroleum ether/EtOAc = 8:1); IR (film) νmax = 2956, 2867, 1735,
1459, 1378, 1093, 879, 743 cm−1; 1H NMR (400 MHz, CDCl3) δ 4.90
(s, 1H), 4.85 (d, 1H, J = 2.4 Hz), 2.76−2.68 (m, 2H), 2.66−2.52 (m,
1H), 2.49−2.40 (m, 2H), 2.33−2.30 (m, 1H), 1.93−1.86 (m, 2H),
1.80−1.73 (m, 1H), 1.65−1.60 (m, 2H), 1.54−1.41 (m, 1H), 1.10 (s,
3H), 1.06 (s, 3H), 1.05 (s, 3H); 13C NMR (100 MHz, CDCl3) δ
224.8, 161.5, 104.7, 57.6, 50.7, 49.2, 48.9, 47.1, 40.4, 34.5, 31.5, 28.4,
24.6, 24.3, 22.3; HRMS (ESI) m/z [M + H]+ calcd for C15H23O,
219.1743; found, 219.1746. Compound 9a: Rf = 0.54 (petroleum
ether/EtOAc = 8:1); IR (film) νmax = 2962, 2867, 1740, 1329, 1129,
(1R,3aR,3bR,6aR,7aR)-2,2,3b-Trimethyldecahydro-1H-
cyclopenta[a]pentalen-1-ol (9d). Compound 9d was prepared by a
procedure analogous to that for compound 9b in 81% yield as a
colorless oil: Rf = 0.31 (petroleum ether/EtOAc = 3:1); IR (film) νmax
1
= 3503, 2933, 2867, 1713, 1427, 1363, 1222, 1091, 901 cm−1; H
NMR (400 MHz, CDCl3) δ 4.83 (s, 1H), 4.77 (d, 1H, J = 2.4 Hz),
3.22 (d, 1H, J = 7.6 Hz), 2.61 (q, 1H, J = 9.6 Hz), 2.51−2.46 (m, 2H),
2.45−2.37 (m, 1H), 2.24−2.15 (m, 1H), 2.13−2.04 (m, 1H), 1.76−
1.70 (m, 1H), 1.65−1.61 (m, 1H), 1.60−1.48 (m, 2H), 1.47−1.40 (m,
1H), 1.01 (s, 3H), 0.91 (s, 6H); 13C NMR (100 MHz, CDCl3) δ
161.7, 104.1, 87.8, 55.8, 50.0, 49.5, 47.6, 42.4, 41.0, 35.5, 29.9, 26.7,
25.4, 22.1, 19.4; HRMS (ESI) m/z [M + H]+ calcd for C15H25O,
221.1900; found, 221.1904.
S-Methyl O-((1R,3aR,3bR,6aR,7aR)-2,2,3b-Trimethyldecahydro-
1H-cyclopenta[a]pentalen-1-yl) Carbonodithioate (10). A mixture
of compound 9d (25 mg, 0.11 mmol), NaH (18 mg, 0.75 mmol), and
imidazole (2 mg, 0.03 mmol) in dry THF (2 mL) in a 10 mL three-
necked flask was refluxed with stirring for 3 h under nitrogen, and a
mixture of carbon disulfide (0.30 mL, 5.00 mmol) in 1 mL of THF was
added dropwise. After refluxing for 45 min, methyl iodide (0.50 mL,
8.00 mmol) was added to the reaction mixture and refluxed for
another 30 min. The reaction mixture was quenched with acetic acid
(0.15 mL), diluted with water, and extracted with ether. The ethereal
layer was washed with water, dried over Na2SO4, and concentrated in
vacuo. The residue was purified by flash silica gel column
chromatography (petroleum ether/EtOAc = 15:1) to give xanthate
derivative 10 (28 mg, 81%) as a colorless oil: Rf = 0.70 (petroleum
ether/EtOAc = 10:1); IR (film) νmax = 2947, 2867, 1649, 1460, 1370,
1
1094, 912, 756 cm−1; H NMR (400 MHz, CDCl3) δ 4.94 (s, 1H),
4.65 (s, 1H), 2.49−2.35 (m, 4H), 2.22−2.09 (m, 2H), 1.73−1.70 (m,
1H), 1.56−1.42 (m, 4H), 1.12 (s, 3H), 0.98 (s, 3H), 0.87 (s, 3H); 13C
NMR (100 MHz, CDCl3) δ 223.9, 158.2, 105.8, 56.8, 55.5, 53.1, 49.5,
47.7, 41.7, 35.3, 34.0, 29.9, 29.2, 24.9, 24.4; HRMS (ESI) m/z [M +
H]+ calcd for C15H23O, 219.1743; found, 219.1745.
(1R,3aS,3bR,6aR,7aS)-2,2,3b-Trimethyl-4-methylenedecahydro-
1H-cyclopenta[a]pentalen-1-ol (9b). To a suspension of LiAlH4 (20
mg, 0.53 mmol) in dry Et2O (1.5 mL) at 0 °C was added compound
9a (25 mg, 0.11 mmol) in dry Et2O (1.5 mL) under N2. After stirring
1
1222, 1058, 964, 880 cm−1; H NMR (400 MHz, CDCl3) δ 5.52 (d,
1H, J = 6.4 Hz), 4.83 (s, 1H), 4.78 (d, 1H, J = 2.4 Hz), 2.74−2.69 (m,
1H), 2.58−2.52 (m, 1H), 2.54 (s, 3H), 2.49−2.44 (m, 2H), 2.20−2.16
E
dx.doi.org/10.1021/jo4009854 | J. Org. Chem. XXXX, XXX, XXX−XXX